Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modulation of CD4 T cell function by soluble MHC II-peptide chimeras.

S Casares1, C A Bona, T D Brumeanu

  • 1Department of Microbiology, Mount Sinai School of Medicine, New York, NY 10029, USA.

International Reviews of Immunology
|March 14, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A binding event converted into a folding event.

FEBS letters·2003
Same author

Sensitive detection of GM1 lipid rafts and TCR partitioning in the T cell membrane.

Journal of immunological methods·2003
Same author

Structural cooperativity in the SH3 domain studied by site-directed mutagenesis and amide hydrogen exchange.

FEBS letters·2003
Same author

The temperature dependence of the hydrogen exchange in the SH3 domain of alpha-spectrin.

FEBS letters·2002
Same author

Maintenance of size and function of influenza virus hemagglutinin specific transgenic T-cell clone during life.

Journal of cellular and molecular medicine·2002
Same author

pH dependence of the hydrogen exchange in the SH3 domain of alpha-spectrin.

FEBS letters·2002
Same journal

Regulatory T cells in the tumor microenvironment: Mechanisms and clinical implications.

International reviews of immunology·2026
Same journal

Leptin in metabolic-immune crosstalk: Mechanisms of T cell regulation and implications for autoimmune disease therapy.

International reviews of immunology·2026
Same journal

Metabolic alterations in the tumor microenvironment influence the anti-tumor immune function of CD8<sup>+</sup> T cells via epigenetic modifications.

International reviews of immunology·2026
Same journal

Macrophage markers and gene signature profiling reveals mesenchymal stem cells mediated immune modulation in Plasmodium berghei ANKA infection.

International reviews of immunology·2026
Same journal

Natural antigen landscape shaping intestinal Treg cells: Self, diet, and microbiota.

International reviews of immunology·2026
Same journal

Upregulation of ADAM10 reinforces CD8<sup>+</sup> T cells toward exhaustion in the TME.

International reviews of immunology·2026
See all related articles

Soluble MHC class II-peptide chimeras are novel T cell ligands that modulate T cell responses. These engineered molecules show potential for treating autoimmune and infectious diseases by regulating T cell activity.

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • T cell receptor (TCR) recognizes peptide antigens presented by major histocompatibility complex (MHC) molecules on antigen-presenting cells (APCs).
  • TCR and CD4 co-receptor ligation by MHC II-peptide complexes initiates T cell signaling, influencing T cell function based on co-stimulatory signals.
  • Genetic engineering has produced soluble MHC class I- and MHC class II-peptide chimeras as novel TCR ligands.

Purpose of the Study:

  • To review the immunomodulatory effects of soluble MHC class II-peptide chimeras.
  • To discuss the potential therapeutic applications of these chimeras in autoimmune and infectious diseases.
  • To explore the mechanisms of T cell regulation by these engineered ligands.

Main Methods:

  • Review of existing literature on soluble MHC class II-peptide chimeras.

Related Experiment Videos

  • Analysis of T cell activation and regulation by these chimeras in vitro and in vivo.
  • Discussion of theoretical frameworks for T cell modulation.

    • Main Results:

    • Soluble MHC class II-peptide chimeras act as specific ligands for TCR and CD4.
    • These chimeras demonstrate significant regulatory effects on peptide-specific T cells.
    • Observed effects include modulation of T cell responses in both in vitro and in vivo models.

    Conclusions:

    • Soluble MHC class II-peptide chimeras represent a new class of T cell modulators.
    • These engineered molecules hold promise for therapeutic interventions in immune-related diseases.
    • Further research into their mechanisms may reveal new strategies for T cell-targeted therapies.